Follow
Emily Cheney
Emily Cheney
Unknown affiliation
Verified email at alumni.brown.edu
Title
Cited by
Cited by
Year
PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer
C Pantelidou, O Sonzogni, M De Oliveria Taveira, AK Mehta, A Kothari, ...
Cancer discovery 9 (6), 722-737, 2019
5052019
Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer
AK Mehta, EM Cheney, CA Hartl, C Pantelidou, M Oliwa, JA Castrillon, ...
Nature cancer 2 (1), 66-82, 2021
1452021
Dysregulation in actin cytoskeletal organization drives increased stiffness and migratory persistence in polyploidal giant cancer cells
B Xuan, D Ghosh, EM Cheney, EM Clifton, MR Dawson
Scientific reports 8 (1), 11935, 2018
602018
Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer
CA Hartl, A Bertschi, RB Puerto, C Andresen, EM Cheney, EA Mittendorf, ...
Journal for ImmunoTherapy of Cancer 7, 1-17, 2019
352019
Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer
JC Lal, MG Townsend, AK Mehta, M Oliwa, E Miller, A Sotayo, E Cheney, ...
Breast Cancer Research 23, 1-24, 2021
162021
860 Targeting immunosuppressive macrophages overcomes PARP-inhibitor resistance in BRCA1-associated triple-negative breast cancer
A Mehta, E Cheney, C Hartl, C Pantelidou, M Oliwa, J Castrillon, JR Lin, ...
Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020
2020
Use of Murine Models to Identify Tumor Immune Components that Correlate with Response to Immunotherapy in Breast Cancer
JA Castrillon, AK Mehta, E Cheney, E Miller, A Sotayo, EA Mittendorf, ...
2020
Abstract A81: Identifying cellular immune components that correlate with response to immunotherapy in breast cancer using murine models
AK Mehta, JA Castrillion, A Sotayo, EA Mittendorf, AG Letai, JL Guerriero, ...
Cancer Immunology Research 8 (3_Supplement), A81-A81, 2020
2020
PARP inhibition modulates the infiltration, phenotype, and function of tumor-associated macrophages (TAMs) in BRCA-associated breast cancer and can be augmented by harnessing …
AK Mehta, EM Cheney, JA Castrillon, JR Lin, MO Taveira, CA Hartl, ...
CANCER IMMUNOLOGY RESEARCH 8 (3), 83-83, 2020
2020
Identifying cellular immune components that correlate with response to immunotherapy in breast cancer using murine models.
AK Mehta, JA Castrillion, A Sotayo, EA Mittendorf, AG Letai, JL Guerriero, ...
CANCER IMMUNOLOGY RESEARCH 8 (3), 71-72, 2020
2020
Abstract A105: PARP inhibition modulates the infiltration, phenotype, and function of tumor-associated macrophages (TAMs) in BRCA-associated breast cancer and can be augmented …
AK Mehta, EM Cheney, JA Castrillon, JR Lin, MO Taveira, CA Hartl, ...
Cancer Immunology Research 8 (3_Supplement), A105-A105, 2020
2020
Abstract P5-04-01: PARP inhibition modulates the infiltration, phenotype and function of tumor-associated macrophages (TAMs) in BRCA-associated breast cancer and can be …
JL Guerriero, AK Mehta, EM Cheney, JA Castrillon, JR Lin, MO Taveira, ...
Cancer Research 80 (4_Supplement), P5-04-01-P5-04-01, 2020
2020
PARP inhibition modulates the infiltration, phenotype and function of tumor-associated macrophages (TAMs) in BRCA-associated breast cancer and can be augmented by harnessing …
JL Guerriero, AK Mehta, EM Cheney, JA Castrillon, JR Lin, MO Taveira, ...
CANCER RESEARCH 80 (4), 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–13